Stocks
Denali Therapeutics (DNLI) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -8.43 | 128.3 | -18.7 | -10.7 | -20.3 | -7.77 | ||
| Changes by years, y/y, % | -84% | -1 622% | -115% | -43% | +90% | -17.4% | |||
Denali Therapeutics. P/E
Denali Therapeutics. P/E, changes, %
Denali Therapeutics (DNLI) P/E US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/E | ? | -22.8 | -20.4 | -22.3 | -9.34 | -11.5 | -7.77 | |
| Changes by years, y/y, % | +81% | +80% | +163% | -70% | -49% | |||
| Changes by quarters, q/q, % | -28% | -10% | +9% | -58% | +24% | |||
